These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 22282655

  • 1. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY.
    Cancer Res; 2012 Mar 01; 72(5):1092-102. PubMed ID: 22282655
    [Abstract] [Full Text] [Related]

  • 2. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C.
    Prostate; 2006 Feb 15; 66(3):235-47. PubMed ID: 16173028
    [Abstract] [Full Text] [Related]

  • 3. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q, Yang X, Pins M, Javonovic B, Kuzel T, Kim SJ, Parijs LV, Greenberg NM, Liu V, Guo Y, Lee C.
    Cancer Res; 2005 Mar 01; 65(5):1761-9. PubMed ID: 15753372
    [Abstract] [Full Text] [Related]

  • 4. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
    J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475
    [Abstract] [Full Text] [Related]

  • 5. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A.
    J Immunol; 2012 Dec 15; 189(12):5602-11. PubMed ID: 23152559
    [Abstract] [Full Text] [Related]

  • 6. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, Schilham MW, Hogendoorn PC, Lankester AC.
    J Pathol; 2011 Feb 15; 223(3):347-57. PubMed ID: 21171080
    [Abstract] [Full Text] [Related]

  • 7. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM.
    Clin Cancer Res; 2004 Sep 01; 10(17):5907-18. PubMed ID: 15355924
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 9. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W, Ohtani H, Nakayama T, Sugawara Y, Sato E, Nagura H, Yoshie O, Sasano T.
    Am J Pathol; 2003 Jul 01; 163(1):261-8. PubMed ID: 12819030
    [Abstract] [Full Text] [Related]

  • 10. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
    Franciszkiewicz K, Le Floc'h A, Jalil A, Vigant F, Robert T, Vergnon I, Mackiewicz A, Benihoud K, Validire P, Chouaib S, Combadière C, Mami-Chouaib F.
    Cancer Res; 2009 Aug 01; 69(15):6249-55. PubMed ID: 19638592
    [Abstract] [Full Text] [Related]

  • 11. Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells.
    González-Martín A, Gómez L, Lustgarten J, Mira E, Mañes S.
    Cancer Res; 2011 Aug 15; 71(16):5455-66. PubMed ID: 21715565
    [Abstract] [Full Text] [Related]

  • 12. Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses.
    Dercamp C, Chemin K, Caux C, Trinchieri G, Vicari AP.
    Cancer Res; 2005 Sep 15; 65(18):8479-86. PubMed ID: 16166328
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 14. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
    Wang L, Wen W, Yuan J, Helfand B, Li Y, Shi C, Tian F, Zheng J, Wang F, Chen L, Liang L, Zhou L, Lee C, Chen Z, Guo Y, Wang H, Zhang Q, Qin W.
    Clin Cancer Res; 2010 Jan 01; 16(1):164-73. PubMed ID: 20028741
    [Abstract] [Full Text] [Related]

  • 15. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
    Cueto FJ, Del Fresno C, Brandi P, Combes AJ, Hernández-García E, Sánchez-Paulete AR, Enamorado M, Bromley CP, Gomez MJ, Conde-Garrosa R, Mañes S, Zelenay S, Melero I, Iborra S, Krummel MF, Sancho D.
    J Immunother Cancer; 2021 May 01; 9(5):. PubMed ID: 33980589
    [Abstract] [Full Text] [Related]

  • 16. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
    Sun Y, Peng D, Lecanda J, Schmitz V, Barajas M, Qian C, Prieto J.
    Gene Ther; 2000 Sep 01; 7(17):1467-76. PubMed ID: 11001366
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

  • 18. Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum.
    Tanaka K, Matsui Y, Ishikawa S, Kawanishi T, Harada M.
    Oncol Rep; 2012 Feb 15; 27(2):325-32. PubMed ID: 22086364
    [Abstract] [Full Text] [Related]

  • 19. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression.
    Chen JP, Liao NS, Lai SL, Hsu L, Mao WY, Ku MC, Liao F.
    Eur J Immunol; 2005 Mar 15; 35(3):690-8. PubMed ID: 15719370
    [Abstract] [Full Text] [Related]

  • 20. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, Colombo MP.
    Eur J Immunol; 1995 Jan 15; 25(1):137-46. PubMed ID: 7843224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.